Rheumatoid Arthritis Clinical Trials

Showing 20421-20440 of 47,334 trials

99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients

NCT02723760

This is an open-label SPECT/CT (single photon emission computed tomography/computed tomography) study to investigate the diagnosis and efficacy evaluation performance of 99mTc-3PRGD2 in rheumatoid arthritis patients. A single dose of nearly 11.1 MBq/kg body weight of 99mTc-3PRGD2 (≤20µg 3PRGD2) will be intravenously injected into the patients. Visual and semiquantitative method will be used to assess the whole-body planar and lesions section SPECT/CT images. Adverse events will also be observed in the patients.

Rheumatoid Arthritis

First Affiliated Hospital of Fujian Medical University4 participantsStarted Nov 2015

Fuzhou, Fujian, China

COMPLETEDPhase 4

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:

NCT06043544

This monocentric randomized open-label study aims to assess the efficacy and safety of a treatment with medium molecular weight hyaluronic acid (HA) compared to a treatment with corticosteroids on patients affected by glenohumeral osteoarthritis.

Glenohumeral Osteoarthritis

Concordia Hospital Rome80 participantsStarted May 2021

Rome, Italy

UNKNOWNNA

Assessment and Remediation of Oral Disorders

NCT06046768

As part of the Reference Center for Rare Diseases of the Robert Debré Hospital, many children have eating and verbal oral disorders. In this doctoral research, we question the psychological impact of oral disorders on the dynamics of family functioning.Our research entitled: Evaluation and Remediation of Orality Disorders (ERTO) aims to evaluate the impact of psychological care of the child and a support program for parents. We hypothesized that this comprehensive management could contribute to improving disorders and consequently modify parental representations of the child and his disorders. In addition, care focused on intra-family relations and communication would allow a decentralization and a repositioning of the problem of disorders within the family dynamic. The results of this research will have concrete applications for the management of children suffering from oral disorders.

Oral Disorder

Assistance Publique - Hôpitaux de Paris16 participantsStarted Oct 2023

Paris, France

99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:

Assessment and Remediation of Oral Disorders

Related Searches

Symptom Burden Guiding Invasive Electrophysiological Study in Paroxysmal Supraventricular Tachycardia

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease

Opioid Free Pterygopalatine Ganglion Block Based Multimodal Anesthesia for Tonsillectomy Operations

Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function

Biomarkers and Risk Factors for Perioperative Neurocognitive Dysfunction in Elderly Patients

NEXUS™ Aortic Arch Stent Graft System First In Man Study

The Effect of Etelcalcetide on CKD-MBD

Effects of Tai Chi on Postural Balance and Quality of Life in the Elderly With Gait Disorder

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

In Vitro Analysis of Human Urine With the CloudCath Device

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping